Companies›Healthcare›Healthcare›Pharmaceuticals & Biotechnology

FABINO ENTERPRISES LIMITED

Healthcare › Pharmaceuticals & Biotechnology
₹20.31
at close · 27 Apr 2026
▲ 0.96 (+4.96%)

Latest filings

  1. Routine SEBI compliance filing confirms no demat or remat requests in Q2 · Compliance
  2. Change of control at Fabino: Old promoters exit, new promoters take over · Ownership Changes
  3. Fabino Enterprises to rename as Raavi Greenz Resources, pivot to biofuel business · Strategic Transactions
All filings ↓
Ask Nexa about FABINO ENTERPRISES LIMITED

Snapshot

What the business is, and whether it's a good one at a fair price.

A Pharmaceuticals & Biotechnology company listed on BSE, reporting revenue of ₹39 Cr over the trailing twelve months.

Market Cap
₹4 Cr
P / E (TTM)
6.9×
EV / EBITDA
—
Div Yield
—
Growth
—·
Revenue 5y CAGR
PAT — · EBITDA —
Quality
-11.5%·
ROCE (FY26)
ROE — · margin —
Leverage
—·
Debt / Equity · borrowings not filed
Revenue FY24→FY26
1.0×▼
Revenue change
₹21 Cr → ₹21 Cr
Where it sits among 185 Pharmaceuticals peersBar = share of peers beaten · tick = industry median · latest reported figures
P/E (TTM)#9/158
ROCE#170/183
Revenue growth#14/161

Scorecard

Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice

Strengths
Nothing stands out in the filed numbers.
Concerns
Negative returns on capital — −11.5%
#170 of 183 in Pharmaceuticals on the latest reported figures

Charts

How has the market priced it — with filings on the timeline?

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Peers

How does it stack up on valuation, returns and growth?

Loading peers…

Financials

Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.

Loading financials…

Ownership

Who owns it — and is the promoter stake clean?

Loading shareholding…

Sign up to see the full company file

Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.

Common questions

Answered from FABINO ENTERPRISES LIMITED's filed financials and exchange disclosures

What does FABINO ENTERPRISES LIMITED do?

FABINO ENTERPRISES LIMITED is a Pharmaceuticals & Biotechnology company listed on BSE.

Is FABINO ENTERPRISES LIMITED expensive compared with its peers?

On trailing P/E, FABINO ENTERPRISES LIMITED ranks 9 of 158 in Pharmaceuticals — cheaper than 95% of them, against an industry median of 29.8×. This is a position, not a valuation judgement.

Where can I track FABINO ENTERPRISES LIMITED's announcements?

Every NSE and BSE filing by FABINO ENTERPRISES LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.

Figures are as last reported and may lag the latest filing. Not investment advice.